Intellia Therapeutics (NTLA) PT Lowered to $165 at JMP Securities
Tweet
Share
E-mailGet Alerts NTLA Hot Sheet
Price: $12.09 --0%
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 18
Rating Summary:
23 Buy, 9 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 18
Join SI Premium – FREE
JMP Securities analyst Silvan Tuerkcan lowered the price target on Intellia Therapeutics (NASDAQ: NTLA) to $165.00 (from $175.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades China Literature (772:HK) (CHLLF) to Neutral
- Zensho Holdings (7550:JP) PT Raised to JPY13,300 at Nomura/Instinet
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
